Hospitalized patients with COVID-19 who required intensive care unit (ICU) treatment were more likely to acquire infections than those hospitalized with influenza, according to a new study in Scientific Reports.
The rapid test is the latest scientific advancement against bird flu and comes from Alveo Technologies Inc. (California), a leader in molecular sensing and diagnostics with a proprietary technology platform.
Recent Comments